UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Krystal Biotech
KRYS
$9.66B
| $32.2M | 0.01% |
234,320
-341,186
| -59% | -$50.1M |
|
852
Dropbox
DBX
$8.12B
| $32.2M | 0.01% |
1,124,695
+166,219
| +17% | +$4.71M |
|
853
Knife River
KNF
$3.79B
| $32.2M | 0.01% |
393,969
+166,404
| +73% | +$15.2M |
|
854
Flowserve
FLS
$10.2B
| $32.2M | 0.01% |
614,356
-20,490
| -3% | -$964K |
|
855
Repligen
RGEN
$9.25B
| $32.2M | 0.01% |
258,571
+6,074
| +2% | +$773K |
|
856
Jefferies Financial Group
JEF
$13.1B
| $32.1M | 0.01% |
587,585
+149,746
| +34% | +$7.41M |
|
857
Shift4
FOUR
$3.26B
| $32.1M | 0.01% |
323,982
+24,244
| +8% | +$2.11M |
|
|
COOP
858
DELISTED
Mr. Cooper
COOP
| $32.1M | 0.01% |
215,112
+78,438
| +57% | +$10.1M |
|
859
MKS Inc
MKSI
$20.6B
| $32M | 0.01% |
321,712
+54,291
| +20% | +$4.41M |
|
860
Medpace
MEDP
$16.5B
| $31.8M | 0.01% |
101,443
+19,626
| +24% | +$5.89M |
|
861
Lamb Weston
LW
$7.19B
| $31.8M | 0.01% |
613,867
+184,704
| +43% | +$9.89M |
|
862
Varonis Systems
VRNS
$5B
| $31.8M | 0.01% |
626,732
+7,475
| +1% | +$340K |
|
863
Option Care Health
OPCH
$3.56B
| $31.7M | 0.01% |
975,325
-576,534
| -37% | -$18.6M |
|
864
Bath & Body Works
BBWI
$4.1B
| $31.7M | 0.01% |
1,057,309
+494,552
| +88% | +$14.5M |
|
865
Affiliated Managers Group
AMG
$9.76B
| $31.5M | 0.01% |
160,277
+18,544
| +13% | +$3.22M |
|
866
Highwoods Properties
HIW
$3.47B
| $31.5M | 0.01% |
1,012,324
+867,514
| +599% | +$25.5M |
|
867
Roivant Sciences
ROIV
$26.2B
| $31.3M | 0.01% |
2,775,349
+329,542
| +13% | +$3.57M |
|
868
Ionis Pharmaceuticals
IONS
$9.4B
| $31.3M | 0.01% |
791,072
+131,637
| +20% | +$4.31M |
|
869
Franco-Nevada
FNV
$46B
| $31.2M | 0.01% |
190,433
-63,209
| -25% | -$10.5M |
|
870
Five Below
FIVE
$13.5B
| $31.2M | 0.01% |
237,796
+53,278
| +29% | +$5.19M |
|
871
GitLab
GTLB
$6.58B
| $31.2M | 0.01% |
691,342
+105,689
| +18% | +$4.83M |
|
872
UMB Financial
UMBF
$11.1B
| $31.2M | 0.01% |
296,267
+88,386
| +43% | +$8.81M |
|
873
Equity Residential
EQR
$25.1B
| $31.1M | 0.01% |
461,133
-4,235,042
| -90% | -$291M |
|
874
RLI Corp
RLI
$5.89B
| $31.1M | 0.01% |
430,822
+50,090
| +13% | +$3.76M |
|
|
TLN
875
Talen Energy Corp
TLN
$16.7B
| $31.1M | 0.01% |
106,844
+57,794
| +118% | +$13.7M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.